RecruitingNCT06515821

Multicentre Study for Data Collection, Development, and Evaluation of Novel CRC Screening and Diagnostic Methods

Multicentre Observational Study for the Data Collection, Development and Evaluation of the Performance of Novel CRC Screening and Diagnostic Methods ONCOSCREEN-CS


Sponsor

Firalis SA

Enrollment

4,100 participants

Start Date

Aug 1, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

The primary goal is to develop easy accessible diagnostic tools for high risk subjects for colon cancer in different European populations to improve early CRC detection. These CRC screening technologies would be low cost, breakthrough and of high sensitivity and specificity.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is developing and testing new screening and diagnostic methods for colorectal cancer (bowel cancer). Researchers are comparing standard bowel cancer screening tools with new blood and stool tests that might detect cancer or pre-cancerous growths earlier and more easily. **You may be eligible if...** - You are 18 years of age or older - You either have a confirmed bowel cancer diagnosis after colonoscopy, OR you are at higher-than-average risk for bowel cancer (due to family history, obesity, smoking, excess alcohol, or high cholesterol) and are willing to undergo a stool test and colonoscopy, OR you are otherwise healthy with no risk factors and willing to serve as a comparison group - You are covered by a health insurance plan **You may NOT be eligible if...** - You are not covered by health insurance - You are unwilling or unable to complete the required tests (stool test, colonoscopy, or tissue biopsy where required) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTONCOSCREEN

Subjects samples will be tested with diagnostic tests.


Locations(8)

Military Medical Academy Sofia, Gastroenterology Clinic, 3 Sveti Georgi Sofiiski str., Sofia 1606, Bulgaria

Sofia, Bulgaria

University Specialised Hospital for Active Treatment of Oncology Departement of Gastroenterology.

Sofia, Bulgaria

UFC: Université de Franche-Comté Oncology department CHU Besançon

Besançon, France

MKI UKSH Lübeck

Lübeck, Germany

UMC Mainz: University Medical Center Mainz

Mainz-GE, Germany

LSMU: Lithuanian University of Health Sciences Gastroenterology Department,

Kaunas, Lithuania

IPO: Instituto Português de Oncologia

Porto, Portugal

IBO: Institutul Oncologic Prof. Dr. Alexandru Trestioreanu București

Bucharest, Romania

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06515821


Related Trials